Synlogic

Synlogic, Inc. (NASDAQ: SYBX) is a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology.

Headquarters Cambridge, MA
Website www.synlogictx.com
Twitter @synlogic_tx​
Pipeline Phase 2 clinical trials
Partners AbbVie